The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Finley John David since 2021.
This trader's CIK number is 1851034.
At the time of last reporting, Finley John David was the CEO, CFO, Director of Palisade Bio, Inc.. (stock ticker symbol PALI).
Also see all insider trading activities at Palisade Bio, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | PALI | 21,000 | $15,090 | 0 | $0 | 21,020 | $0 |
| 2023 | PALI | 30,000 | $17,910 | 0 | $0 | 19,910 | $0 |
| 2022 | PALI | 134,331 | $37,156 | 0 | $0 | 0 | $0 |
| 2021 | PALI | 12,000 | $31,280 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-05-28 | PALI | Option Ex | 7,068 | .00 | 0 |
| 2024-05-24 | PALI | Buy | 1,000 | 4.81 | 4,810 |
| 2024-05-06 | PALI | Option Ex | 443 | .00 | 0 |
| 2024-03-11 | PALI | Option Ex | 5,558 | .00 | 0 |
| 2024-02-06 | PALI | Option Ex | 6,642 | .00 | 0 |
| 2024-02-06 | PALI | Buy | 10,000 | .47 | 4,690 |
| 2024-01-31 | PALI | Buy | 10,000 | .56 | 5,590 |
| 2024-01-03 | PALI | Option Ex | 1,309 | .00 | 0 |
| 2023-11-06 | PALI | Option Ex | 3,475 | .00 | 0 |
| 2023-10-03 | PALI | Option Ex | 1,309 | .00 | 0 |
| 2023-09-27 | PALI | Buy | 15,000 | .54 | 8,085 |
| 2023-09-13 | PALI | Buy | 15,000 | .66 | 9,825 |
| 2023-09-11 | PALI | Option Ex | 5,558 | .00 | 0 |
| 2023-08-06 | PALI | Option Ex | 3,475 | .00 | 0 |
| 2023-07-03 | PALI | Option Ex | 1,309 | .00 | 0 |
| 2023-06-12 | PALI | Option Ex | 3,475 | .00 | 0 |
| 2023-04-03 | PALI | Option Ex | 1,309 | .00 | 0 |
| 2022-09-01 | PALI | Buy | 19,481 | .14 | 2,805 |
| 2022-08-23 | PALI | Buy | 7,350 | .16 | 1,176 |
| 2022-08-16 | PALI | Buy | 100,000 | .25 | 25,000 |
| 2022-03-24 | PALI | Buy | 7,500 | 1.09 | 8,175 |
| 2021-09-21 | PALI | Buy | 2,000 | 2.44 | 4,880 |
| 2021-08-27 | PALI | Buy | 10,000 | 2.64 | 26,400 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Finley John David (CEO, CFO, Director of Palisade Bio, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.